Public SEC Form D records
Biotech Series C Form D filings - July 2026
This page lists the 7 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series C stage in July 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 7
- Issuers
- 6
- Combined disclosed
- $424.1M
Directory links
Filing records
7 crawlable filing links in this facet.
- Ratio Therapeutics, Inc.July 31, 2026 / Reg D 506(b) / MA$70.0M
- Trailhead Biosystems Inc.July 30, 2026 / Reg D 506(b) / OH$40.4M
- Trailhead Biosystems Inc.July 30, 2026 / Reg D 506(b) / OH$40.6M
- Cue Biopharma, Inc.July 22, 2026 / Reg D 506(b) / MA$50.0M
- Baylor Genetics Holdings, Inc.July 16, 2026 / Reg D 506(b) / TX$100.0M
- Dewpoint Therapeutics, Inc.July 13, 2026 / Reg D 506(b) / MA$82.3M
- Jaguar Health, Inc.July 1, 2026 / Reg D 506(b) / CA$40.8M